Group One Trading, L.P. Syndax Pharmaceuticals Inc Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 11,752 shares of SNDX stock, worth $153,716. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,752

Previous 2,318 406.99%

Holding current value

$153,716

Previous $47,000 380.85%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $169,151 - $234,057	9,434 Added 406.99%	11,752 $226,000
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $29,265 - $36,993	1,555 Added 203.8%	2,318 $47,000
Q1 2024 May 10, 2024	SELL	$19.71 - $24.57 $494,208 - $616,068	-25,074 Reduced 97.05%	763 $18,000
Q4 2023 Feb 14, 2024	SELL	$11.39 - $21.67 $988,811 - $1.88 Million	-86,814 Reduced 77.06%	25,837 $558,000
Q3 2023 Nov 09, 2023	BUY	$14.52 - $21.77 $1.62 Million - $2.42 Million	111,374 Added 8721.53%	112,651 $1.64 Million
Q2 2023 Aug 09, 2023	SELL	$19.35 - $22.31 $17,028 - $19,632	-880 Reduced 40.8%	1,277 $26,000
Q1 2023 May 12, 2023	BUY	$20.66 - $28.98 $20,660 - $28,980	1,000 Added 86.43%	2,157 $45,000
Q4 2022 Feb 09, 2023	BUY	$20.64 - $26.24 $23,880 - $30,359	1,157 New	1,157 $29,000
Q3 2021 Nov 12, 2021	SELL	$13.87 - $19.8 $94,426 - $134,798	-6,808 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$13.42 - $25.18 $34,516 - $64,762	2,572 Added 60.72%	6,808 $117,000
Q1 2021 May 12, 2021	SELL	$19.28 - $24.59 $188,654 - $240,613	-9,785 Reduced 69.79%	4,236 $95,000
Q4 2020 Feb 10, 2021	BUY	$15.1 - $26.44 $211,717 - $370,715	14,021 New	14,021 $312,000
Q1 2020 May 13, 2020	SELL	$6.65 - $12.03 $140,527 - $254,217	-21,132 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$5.43 - $9.22 $4,637 - $7,873	-854 Reduced 3.88%	21,132 $186,000
Q3 2019 Nov 12, 2019	BUY	$7.47 - $10.76 $14,118 - $20,336	1,890 Added 9.4%	21,986 $164,000
Q2 2019 Aug 09, 2019	BUY	$4.9 - $9.31 $66,169 - $125,722	13,504 Added 204.85%	20,096 $187,000
Q1 2019 May 13, 2019	SELL	$4.26 - $6.86 $24,149 - $38,889	-5,669 Reduced 46.24%	6,592 $35,000
Q4 2018 Feb 06, 2019	BUY	$3.6 - $8.42 $11,685 - $27,331	3,246 Added 36.01%	12,261 $55,000
Q3 2018 Nov 08, 2018	BUY	$6.33 - $8.08 $55,558 - $70,918	8,777 Added 3687.82%	9,015 $73,000
Q2 2018 Aug 14, 2018	BUY	$6.93 - $14.63 $1,649 - $3,481	238 New	238 $2,000
Q1 2018 May 11, 2018	SELL	$8.71 - $14.82 $34,840 - $59,280	-4,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$7.8 - $12.94 $31,200 - $51,760	4,000	4,000 $35,000

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Syndax Pharmaceuticals Inc Transaction History